Aims: Antiplatelet treatment can cause a change in plasma levels of platelet microRNAs (miRNAs). However, it is not clear whether the plasma level of platelet miRNAs can predict clinical
1. Medical Research Center of Guangdong General Hospital, Guangzhou, Guangdong, China; 2. Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China; 3. Sun Yat-sen M
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
adverse cardiovascular eventsbleedingdual antiplatelet therapymir-126percutaneous coronary interventionplasma mirna
Read next articleOptimisation of transcatheter aortic balloon-expandable valve deployment: the two-step inflation technique